BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 24157562)

  • 41. Antithrombotic medication for stroke prevention.
    Weimar C; Weber R; Diener HC
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1245-54. PubMed ID: 19814667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient ischemic attack: risk stratification and treatment.
    Cucchiara B; Ross M
    Ann Emerg Med; 2008 Aug; 52(2):S27-39. PubMed ID: 18655916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
    Calvet D; Bracard S; Mas JL;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.
    Sandercock P; Lindley R; Wardlaw J
    Br J Hosp Med; 1992 May 20-Jun 2; 47(10):731-7. PubMed ID: 1606457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation.
    Manaktala R; Kluger J
    J Am Osteopath Assoc; 2017 Dec; 117(12):761-771. PubMed ID: 29181519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation).
    Easton JD
    Curr Atheroscler Rep; 2011 Aug; 13(4):314-20. PubMed ID: 21584696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early Initiation of Anticoagulation with Direct Oral Anticoagulants in Patients after Transient Ischemic Attack or Ischemic Stroke.
    Macha K; Volbers B; Bobinger T; Kurka N; Breuer L; Huttner HB; Schwab S; Köhrmann M
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2317-21. PubMed ID: 27449113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.
    Kapil N; Datta YH; Alakbarova N; Bershad E; Selim M; Liebeskind DS; Bachour O; Rao GHR; Divani AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):301-318. PubMed ID: 27461564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Update on antithrombotic secondary prevention of ischemic stroke].
    Köhrmann M; Kleinschnitz C
    Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urgent need for secondary stroke prevention after transient ischemic attack.
    Fagan SC
    Consult Pharm; 2008 Feb; 23(2):131-40. PubMed ID: 18454579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A benefit-risk assessment of agents used in the secondary prevention of stroke.
    MacWalter RS; Shirley CP
    Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stroke prevention.
    Isabel C; Calvet D; Mas JL
    Presse Med; 2016 Dec; 45(12 Pt 2):e457-e471. PubMed ID: 27816341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis.
    Wong KS; Wang Y; Leng X; Mao C; Tang J; Bath PM; Markus HS; Gorelick PB; Liu L; Lin W; Wang Y
    Circulation; 2013 Oct; 128(15):1656-66. PubMed ID: 24030500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
    Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
    Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secondary prevention of stroke: a practical guide to drug treatment.
    Koennecke HC
    CNS Drugs; 2004; 18(4):221-41. PubMed ID: 15015903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.